Dr. Evan Chris Chen, MD

Dr. Chen practices at Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham.

Dr. Chen's NPI, 1679929574, was assigned on May 10, 2016. Dr. Chen graduated from Stanford University School of Medicine in 2016. Dr. Chen holds Massachusetts license 278136.

Dr. Chen's primary practice is Brigham and Women's Hospital, at 75 Francis Street, Boston, MA 02115 in Suffolk County. The practice phone is (617) 732-5500.

Dr. Chen's primary practice is Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham. Dr. Chen is also affiliated with Dana-Farber Cancer Institute. The medical group on file is Massachusetts General Physicians Organization (MGPO). Dmand AI also links Dr. Chen to 1 more hospital, 3 medical groups, 1 home health agency and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chen practices, 5 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Chen's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Chen is licensed in Massachusetts.

CMS data shows 262 Medicare services from Dr. Chen across 5 procedure codes in 2024, for 93 Medicare patients. Medicare paid $25,172 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 93 Medicare patients who saw Dr. Chen in 2024. The largest group is 75 to 84, with 43 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 2.98, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chen's median patient age at 72, with 42% women.

In 2024, Dr. Chen wrote 241 Medicare Part D claims for 43 patients. 72% of them were for generic drugs. CMS names the drug for 118 of them, across 7 drugs with 11 or more claims each, at $167,684 in total drug cost. In 2023, CMS named 129 claims across 7 drugs.

Dr. Chen accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Chen as offering telehealth.

Dmand AI links 32 papers to Dr. Chen, published from 2018 to 2025. 2024 was the busiest year, with 7. The most frequent topics are Leukemia, Myeloid, Acute, Antineoplastic Combined Chemotherapy Protocols and Hematopoietic Stem Cell Transplantation. Dr. Chen has published most often in Blood Adv. Dr. Chen's most frequent co-authors are Daniel Joseph Deangelo, MD, PhD, Marlise Rachael Luskin, MD and Shai Shimony, MD.

CMS Open Payments shows 31 general payments to Dr. Chen from 7 drug and device companies from 2020 to 2025. Consulting fees make up the largest share, 70% of the total. Merck Sharp & Dohme Corporation paid the most, $10,102.

Dr. Chen graduated from Stanford University School of Medicine in 2016.